Amundi trimmed its stake in Equifax, Inc. (NYSE:EFX - Free Report) by 9.3% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 602,081 shares of the credit services provider's stock after selling 61,484 shares during the period. Amundi owned about 0.51% of Equifax worth $95,562,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently made changes to their positions in EFX. Cullen Frost Bankers Inc. acquired a new position in Equifax during the fourth quarter worth $25,000. Ameriflex Group Inc. grew its stake in shares of Equifax by 612.5% in the fourth quarter. Ameriflex Group Inc. now owns 114 shares of the credit services provider's stock valued at $25,000 after buying an additional 98 shares in the last quarter. Reflection Asset Management acquired a new stake in shares of Equifax in the fourth quarter valued at $26,000. Kemnay Advisory Services Inc. purchased a new stake in shares of Equifax in the 4th quarter valued at $26,000. Finally, Clearstead Trust LLC purchased a new stake in shares of Equifax in the 2nd quarter valued at $28,000. Hedge funds and other institutional investors own 96.20% of the company's stock.
Equifax Stock Down 2.0%
EFX stock opened at $168.12 on Thursday. The company's 50 day moving average price is $179.28 and its 200 day moving average price is $177.34. The firm has a market capitalization of $19.75 billion, a price-to-earnings ratio of 29.55, a PEG ratio of 1.67 and a beta of 1.31. Equifax, Inc. has a fifty-two week low of $150.74 and a fifty-two week high of $271.84. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.60 and a current ratio of 0.60.
Equifax (NYSE:EFX - Get Free Report) last issued its quarterly earnings results on Tuesday, July 21st. The credit services provider reported $2.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.20 by $0.05. Equifax had a net margin of 10.73% and a return on equity of 21.61%. The company had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.70 billion. During the same quarter in the previous year, the firm earned $2.00 earnings per share. The firm's quarterly revenue was up 10.6% on a year-over-year basis. Equifax has set its Q3 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.390-8.690 EPS. On average, equities research analysts anticipate that Equifax, Inc. will post 8.55 EPS for the current fiscal year.
Equifax Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Monday, August 31st will be issued a dividend of $0.56 per share. This represents a $2.24 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend is Monday, August 31st. Equifax's payout ratio is 39.37%.
Insider Transactions at Equifax
In other news, EVP John Gamble sold 4,500 shares of the firm's stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $187.96, for a total transaction of $845,820.00. Following the sale, the executive vice president owned 69,055 shares of the company's stock, valued at approximately $12,979,577.80. This trade represents a 6.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mark W. Begor sold 37,791 shares of the business's stock in a transaction that occurred on Friday, July 24th. The stock was sold at an average price of $172.16, for a total value of $6,506,098.56. Following the sale, the chief executive officer owned 271,890 shares of the company's stock, valued at approximately $46,808,582.40. The trade was a 12.20% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is owned by insiders.
Analyst Ratings Changes
A number of equities analysts recently commented on the company. Needham & Company LLC lowered their target price on Equifax from $265.00 to $245.00 and set a "buy" rating for the company in a report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft set a $208.00 price objective on shares of Equifax and gave the company a "buy" rating in a research note on Wednesday, July 22nd. Bank of America reduced their target price on shares of Equifax from $250.00 to $225.00 and set a "buy" rating on the stock in a report on Tuesday, May 19th. Robert W. Baird decreased their price target on shares of Equifax from $245.00 to $232.00 and set an "outperform" rating for the company in a research report on Wednesday, July 22nd. Finally, Mizuho dropped their price target on shares of Equifax from $222.00 to $210.00 and set an "outperform" rating for the company in a research note on Thursday, July 2nd. Fifteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, Equifax has a consensus rating of "Moderate Buy" and a consensus price target of $215.16.
Read Our Latest Analysis on EFX
Equifax Company Profile
(
Free Report)
Equifax Inc NYSE: EFX is a global data, analytics and technology company that provides information solutions to businesses, government agencies and consumers. Its services help organizations assess credit risk, prevent fraud, verify identities, market products and make informed decisions about lending, employment and other transactions.
The company's offerings include consumer and commercial credit reports, credit scores, fraud-prevention and identity-management tools, income and employment verification services, mortgage and housing data, and workforce-management solutions.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.